Bioventus Purchases Neuromodulation Device Firm Bioness

Bioventus has acquired Bioness, a developer of neuromodulation and rehabilitation medical devices, for $45 million.

Santa Clarita, Calif.-based Bioness manufactures electrical stimulation exoskeletal devices for the upper and lower extremities, robotic gait and fall safety systems, and interactive software learning and recovery assessment platforms.

The deal includes $45 million in an upfront payment and an additional $25 million in conditional payments tied to meeting certain milestones.